What is AmeriGuard's earnings per share (EPS)?

AmeriGuard (AGSS) reported diluted earnings per share of -$0.01 for fiscal year 2025. This represents a 77.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

AmeriGuard (AGSS) Financials

AGSS

FY2025 annual

Revenue $23.5M -11.0% YoY

Net Income -$488K +79.1% YoY

EPS (Diluted) -$0.01 +77.6% YoY

Operating Cash Flow -$235K +91.0% YoY

Market Cap $1.7M as of Sep 3, 2026

Price / Sales 0.1x on $23.5M revenue, FY2025

Price / Earnings n/m net loss, so no earnings multiple, FY2025

Price / Book n/m negative shareholder equity, so no book multiple, Q1 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Jul 1, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q1 FY2026, filed Jul 1, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AGSS SEC filings page.

AmeriGuard (AGSS) reported $23.5M in revenue for fiscal year 2025, down 11.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AGSS FY2025 2026-08-30

Ameriguard’s dominant mechanic is margin improvement that still fails to overcome operating costs and a liability-heavy balance sheet.

Operating cash flow improved from -$2.6M in FY2024 to -$235K in FY2025, a recovery that brings cash performance closer to accounting results. Yet FY2025 net loss was -$488K against an operating loss of -$3.1M, so the bottom-line recovery was not a core operating turnaround.

Despite lower FY2025 revenue, gross-profit margin expanded to 13.3% and gross profit reached $3.1M; the margin shift points to mix or direct-cost changes rather than volume-led expansion. Operating income still was -$3.1M, showing that costs and charges below gross profit remained large enough to absorb the improvement.

By FY2025, liabilities exceeded assets and equity remained negative, while the current ratio was 0.3x; this is a balance sheet financed more by obligations than by shareholder capital. The supplied liquidity comparison equaled 37.1 months of reported annual operating outflow, yet financing cash flow was $886K, separating the cash-resource measure from the broader solvency picture.

Financial Health Signals

Financial health score not available

AmeriGuard does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

0.31

AmeriGuard scores 0.31, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/8

AmeriGuard passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality No Cash Backing

N/A

AmeriGuard reported a net loss of $488K while operations used $235K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$3.4M

YoY-52.2%

AmeriGuard generated $3.4M in revenue in Q1 2026. This represents a decrease of 52.2% from the same quarter a year earlier.

EBITDA

-$790K

YoY+38.1%

AmeriGuard's EBITDA was -$790K in Q1 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 38.1% from the same quarter a year earlier.

Net Income

-$843K

YoY+42.7%

AmeriGuard reported -$843K in net income in Q1 2026. This represents an increase of 42.7% from the same quarter a year earlier.

EPS (Diluted)

-$0.01

YoY+39.4%

QoQ-335.0%

AmeriGuard earned -$0.01 per diluted share (EPS) in Q1 2026. This represents an increase of 39.4% from the same quarter a year earlier. Against the prior quarter it is down 335.0%.

Cash & Balance Sheet

Cash & Debt

$216K

YoY-20.2%

QoQ-70.4%

AmeriGuard held $216K in cash as of Q1 2026; long-term debt is not reported for that period.

Shares Outstanding

89M

YoY-5.9%

QoQ0.0%

5Y CAGR+5.5%

AmeriGuard had 89M shares outstanding in Q1 2026. This represents a decrease of 5.9% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q1 2026.

Dividends Per Share

Not reported for Q1 2026.

Margins & Returns

Gross Margin

4.8%

YoY-3.6pp

AmeriGuard's gross margin was 4.8% in Q1 2026, indicating the percentage of revenue retained after direct costs. This is down 3.6 percentage points from the same quarter a year earlier.

Operating Margin

-26.3%

YoY-7.4pp

AmeriGuard's operating margin was -26.3% in Q1 2026, reflecting core business profitability. This is down 7.4 percentage points from the same quarter a year earlier.

Net Margin

-24.6%

YoY-4.1pp

AmeriGuard's net profit margin was -24.6% in Q1 2026, showing the share of revenue converted to profit. This is down 4.1 percentage points from the same quarter a year earlier.

Return on Equity

Not reported for Q1 2026.

Capital Allocation

None of these metrics is reported for Q1 2026.

AGSS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AGSS quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Revenue	N/A	$23.5M-11.0%	$26.4M+26.1%	$21.0M-15.9%	$24.9M+11.2%	$22.4M	N/A	$7.3M+25.9%	$5.8M+305.3%	$1.4M+26.1%	$1.1M
Cost of Revenue	N/A	$20.4M-12.9%	$23.4M+22.3%	$19.2M-12.7%	$21.9M+6.4%	$20.6M	N/A	$4.1M+43.5%	$2.8M+497.4%	$474K+61.1%	$294K
Gross Profit	N/A	$3.1M+4.3%	$3.0M+66.1%	$1.8M-39.8%	$3.0M+65.4%	$1.8M	N/A	$3.2M+9.1%	$3.0M+210.4%	$959K+13.9%	$842K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$64K-31.1%	$93K+26.9%	$74K
SG&A Expenses	N/A	$1.1M+46.0%	$763K+26.0%	$606K+28.8%	$470K+9842.4%	$5K-41.7%	$8K	$7.0M+82.1%	$3.9M+95.0%	$2.0M+232.2%	$595K
Operating Income	N/A	-$3.1M+7.9%	-$3.4M-40.1%	-$2.4M-2850.6%	-$82K-164.3%	$128K+117.2%	-$746K	-$4.8M-383.6%	-$992K+13.2%	-$1.1M-827.2%	$157K
EBITDA	N/A	-$2.8M+12.4%	-$3.2M-33.1%	-$2.4M-5940.1%	-$39K-121.8%	$180K	N/A	-$4.7M-400.8%	-$941K+15.3%	-$1.1M-739.6%	$174K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$927K+99.2%	$465K+1479.2%	$29K+99.1%	$15K
Income Tax	N/A	$651-81.7%	$4K+580.1%	-$742-107.2%	$10K-69.5%	$34K	N/A	N/A	N/A	$0	$0
Net Income	N/A	-$488K+79.1%	-$2.3M-2354.8%	$104K+123.7%	-$437K-564.1%	$94K+540.1%	-$21K	-$5.5M-275.5%	-$1.5M-24.4%	-$1.2M-923.5%	$142K
EPS (Basic)	N/A	-$0.01+77.6%	-$0.02-2336.4%	$0.00+126.8%	$0.00	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	—	-$0.01+77.6%	-$0.02-2336.4%	$0.00+123.9%	$0.00	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	89M-5.9%	95M0.0%	95M0.0%	95M	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Revenue	$3.4M-52.2%	N/A	N/A	N/A	$7.2M+21.8%	N/A	$7.0M+25.5%	N/A
Cost of Revenue	$3.3M-50.3%	N/A	N/A	N/A	$6.6M+28.4%	N/A	$6.1M+30.6%	N/A
Gross Profit	$163K-72.9%	N/A	N/A	N/A	$601K-21.7%	N/A	$894K-0.7%	N/A
SG&A Expenses	$270K-51.0%	N/A	N/A	N/A	$552K+158.0%	N/A	$206K+48.2%	N/A
Operating Income	-$902K+33.5%	N/A	N/A	N/A	-$1.4M-57.3%	N/A	-$503K-225.8%	N/A
EBITDA	-$790K+38.1%	N/A	N/A	N/A	-$1.3M-55.6%	N/A	-$442K-251.5%	N/A
Net Income	-$843K+42.7%	N/A	N/A	N/A	-$1.5M-72.1%	N/A	-$493K-136.1%	N/A
EPS (Basic)	-$0.01+39.4%	$0.00+169.0%	N/A	N/A	-$0.02-72.2%	-$0.01+18.3%	N/A	N/A
EPS (Diluted)	-$0.01+39.4%	$0.00+169.0%	N/A	N/A	-$0.02-72.2%	-$0.01+18.3%	N/A	N/A
Diluted Shares (Avg)	89M-5.9%	N/A	N/A	N/A	95M0.0%	N/A	N/A	N/A

Not reported in any period shown, so not listed: R&D Expenses, Interest Expense, Income Tax.

AGSS Balance Sheet

AGSS quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Total Assets	$8.2M-16.0%	$9.8M+25.3%	$7.8M+109.0%	$3.7M-18.3%	$4.6M+58.7%	$2.9M	$5.4M+95.3%	$2.8M+277.4%	$737K+23.6%	$596K
Current Assets	$2.6M-21.8%	$3.3M-20.6%	$4.1M+29.3%	$3.2M-28.0%	$4.5M	$0	$5.0M+134.7%	$2.1M+475.9%	$372K+45.3%	$256K
Cash & Equivalents	$729K+71.7%	$425K-80.4%	$2.2M+76.4%	$1.2M-42.4%	$2.1M	$0	$3.1M+241.8%	$893K+350.1%	$199K+262.3%	$55K
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$1.4M-38.9%	$2.3M+47.5%	$1.6M-15.3%	$1.9M-15.6%	$2.2M	N/A	$902K-27.7%	$1.2M+768.5%	$144K-26.1%	$194K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.8M0.0%	$1.8M0.0%	$1.8M	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$11.8M-8.9%	$12.9M+50.1%	$8.6M+50.0%	$5.7M+120.9%	$2.6M+10044.8%	$26K	$9.6M+78.6%	$5.4M+187.8%	$1.9M+300.8%	$465K
Current Liabilities	$7.7M+0.8%	$7.6M+29.3%	$5.9M+109.2%	$2.8M+54.3%	$1.8M+6999.4%	$26K	$7.3M+268.5%	$2.0M+126.4%	$878K+311.8%	$213K
Non-Current Liabilities	$4.1M-22.7%	$5.3M+94.6%	$2.7M-6.6%	$2.9M+276.0%	$781K	$0	$2.3M-33.1%	$3.4M+242.5%	$986K+291.5%	$252K
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	$272K+50.1%	$181K-16.9%	$218K-13.3%	$252K
Total Equity	-$3.5M-13.7%	-$3.1M-298.1%	-$784K+60.8%	-$2.0M-180.4%	$2.5M-13.2%	$2.9M	-$4.2M-60.7%	-$2.6M-129.3%	-$1.1M-960.5%	$131K
Retained Earnings	-$3.8M-14.6%	-$3.3M-247.6%	-$944K+56.2%	-$2.2M-218.7%	$1.8M+118.1%	-$10.0M	N/A	N/A	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Total Assets	$7.9M-15.9%	$8.2M-16.0%	$8.2M+53.1%	$10.0M+99.7%	$9.4M+76.5%	$9.8M+25.3%	$5.4M+31.6%	$5.0M-2.7%
Current Assets	$2.3M-28.3%	$2.6M-21.8%	$2.0M-34.0%	$3.8M+33.3%	$3.2M+0.9%	$3.3M-20.6%	$3.1M-11.4%	$2.8M-37.2%
Cash & Equivalents	$216K-20.2%	$729K+71.7%	$36K-96.0%	$302K-47.8%	$270K-81.4%	$425K-80.4%	$897K-42.4%	$579K-80.6%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	$1.6M-27.6%	$1.4M-38.9%	$1.7M-2.1%	$3.2M+72.6%	$2.2M+67.3%	$2.3M+47.5%	$1.7M-4.2%	$1.8M+29.6%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.8M0.0%	$1.8M0.0%	$1.8M	$1.8M	$1.8M	$1.8M0.0%	N/A	N/A
Total Liabilities	$12.3M-11.9%	$11.8M-8.9%	$12.1M+40.3%	$15.1M+95.8%	$13.9M+82.0%	$12.9M+50.1%	$8.7M+63.6%	$7.7M+26.5%
Current Liabilities	$8.1M-12.8%	$7.7M+0.8%	$7.6M+66.3%	$10.5M+126.1%	$9.3M+104.2%	$7.6M+29.3%	$4.6M+100.8%	$4.7M+52.3%
Non-Current Liabilities	$4.1M-10.1%	$4.1M-22.7%	$4.6M+11.4%	$4.6M+49.5%	$4.6M+49.1%	$5.3M+94.6%	$4.1M+35.7%	$3.1M+0.5%
Total Equity	-$4.4M+3.7%	-$3.5M-13.7%	-$3.9M-19.2%	-$5.2M-88.5%	-$4.6M-94.6%	-$3.1M-298.1%	-$3.3M-172.4%	-$2.7M-179.1%
Retained Earnings	-$4.6M+2.5%	-$3.8M-14.6%	-$4.1M-19.8%	-$5.3M-83.3%	-$4.7M-88.6%	-$3.3M-247.6%	-$3.4M-152.5%	-$2.9M-154.3%

Not reported in any period shown, so not listed: Inventory, Long-Term Debt.

AGSS Cash Flow Statement

AGSS quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Operating Cash Flow	$942K	-$235K+91.0%	-$2.6M-2877.3%	-$88K-134.0%	$258K-6.7%	$277K+1394.0%	-$21K	-$3.4M-98.0%	-$1.7M-2492.0%	-$66K-135.0%	$187K
Depreciation & Amortization	N/A	$361K+51.7%	$238K+377.5%	$50K+16.2%	$43K-17.9%	$52K	N/A	$84K+65.3%	$51K+61.9%	$31K+88.7%	$17K
Stock-Based Compensation	N/A	N/A	N/A	N/A	N/A	$720K0.0%	$720K	$639K	$0-100.0%	$819K	$0
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$10K-50.9%	$21K-55.4%	$47K-85.5%	$325K
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$3.4M-96.2%	-$1.7M-1428.2%	-$113K+18.3%	-$138K
Investing Cash Flow	-$356K	-$346K+58.8%	-$840K-1716.8%	-$46K+79.9%	-$230K+56.1%	-$525K	N/A	-$762K-172.4%	-$280K-495.4%	-$47K+85.5%	-$325K
Financing Cash Flow	-$641K	$886K-48.2%	$1.7M+59.4%	$1.1M+215.3%	-$930K-37.0%	-$679K-3274.1%	$21K	$6.3M+135.1%	$2.7M+943.5%	$256K+108.5%	$123K
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$94K	N/A	N/A

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Operating Cash Flow	-$610K+65.9%	$516K+157.1%	$2.4M+3028.0%	-$1.3M-31.7%	-$1.8M-194.4%	-$903K-76.2%	-$81K+94.6%	-$1.0M-134.3%
Depreciation & Amortization	$112K+42.3%	$99K+20.4%	$96K+56.0%	$88K+64.8%	$79K+91.1%	$83K+661.0%	$61K+113.2%	$53K+85.1%
Investing Cash Flow	-$26K-54.8%	$1+100.0%	-$265K-32.6%	-$64K-23.3%	-$17K+93.5%	-$324K-911.8%	-$200K-1404.6%	-$52K-157.3%
Financing Cash Flow	$123K-92.5%	$177K-76.5%	-$2.4M-497.9%	$1.4M+636.1%	$1.7M+927.6%	$755K-33.5%	$599K+1179.1%	$196K+1357.6%

Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

AGSS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AGSS quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1310-K	FY1210-K	FY1110-K	FY1010-K
Gross Margin	13.3%+1.9pp	11.3%+2.7pp	8.6%-3.4pp	12.0%+3.9pp	8.1%	N/A	44.4%-6.8pp	51.3%-15.7pp	66.9%-7.2pp	74.1%
Operating Margin	-13.3%-0.4pp	-12.9%-1.3pp	-11.6%-11.3pp	-0.3%-0.9pp	0.6%	N/A	-65.6%-48.5pp	-17.1%+62.7pp	-79.7%-93.6pp	13.8%
Net Margin	-2.1%+6.8pp	-8.8%-9.3pp	0.5%+2.2pp	-1.8%-2.2pp	0.4%	N/A	-74.9%-49.8pp	-25.1%+56.7pp	-81.8%-94.3pp	12.5%
Return on Equity	N/A	N/A	N/A	N/A	3.8%+4.5pp	-0.8%	N/A	N/A	N/A	108.6%
Return on Assets	-5.9%+17.9pp	-23.8%-25.1pp	1.3%+13.0pp	-11.7%-13.7pp	2.1%+2.8pp	-0.7%	-100.8%-48.4pp	-52.4%+106.7pp	-159.1%-183.0pp	23.9%
Current Ratio	0.34-0.1x	0.43-0.3x	0.71-0.4x	1.14-1.3x	2.45+2.4x	0.00	0.69-0.4x	1.08+0.7x	0.42-0.8x	1.20
Debt-to-Equity	N/A	N/A	N/A	N/A	1.05+1.0x	0.01	N/A	N/A	N/A	1.92
Asset Turnover	2.86+0.2x	2.690.0x	2.68-4.0x	6.66+1.8x	4.89	N/A	1.35-0.7x	2.09+0.1x	1.950.0x	1.91
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	-46.2%-16.5pp	-29.6%-21.8pp	-7.9%+4.3pp	-12.1%

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q
Gross Margin	4.8%-3.6pp	N/A	N/A	N/A	8.4%-4.7pp	N/A	12.8%-3.4pp	N/A
Operating Margin	-26.3%-7.4pp	N/A	N/A	N/A	-18.9%-4.3pp	N/A	-7.2%-4.4pp	N/A
Net Margin	-24.6%-4.1pp	N/A	N/A	N/A	-20.5%-6.0pp	N/A	-7.1%-3.3pp	N/A
Return on Assets	-10.7%+5.0pp	N/A	N/A	N/A	-15.7%+0.4pp	N/A	-9.2%-4.1pp	N/A
Current Ratio	0.28-0.1x	0.34-0.1x	0.27-0.4x	0.36-0.3x	0.34-0.4x	0.43-0.3x	0.68-0.9x	0.61-0.9x
Asset Turnover	0.44-0.3x	N/A	N/A	N/A	0.77-0.3x	N/A	1.30-0.1x	N/A

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, FCF Margin.

Note: Shareholder equity is negative (-$3.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.34), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
AmeriGuard AGSS	FY2025	$23.5M	-$488K	-2.1%	$1.7M	—
Defense Technologies Intl Corp DTII	FY2025	$0	N/A	N/A	$525K	—
Blue Line Protn Group Inc BLPG	FY2024	$4.4M	$242K	5.5%	$280K	—

Where AmeriGuard Ranks

Frequently Asked Questions

What is AmeriGuard's annual revenue?

AmeriGuard (AGSS) reported $23.5M in total revenue for fiscal year 2025. This represents a -11.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is AmeriGuard's revenue growing?

AmeriGuard (AGSS) revenue declined by 11.0% year-over-year, from $26.4M to $23.5M in fiscal year 2025.

Is AmeriGuard profitable?

No, AmeriGuard (AGSS) reported a net income of -$488K in fiscal year 2025, with a net profit margin of -2.1%.

What is AmeriGuard's EBITDA?

AmeriGuard (AGSS) had EBITDA of -$2.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is AmeriGuard's gross margin?

AmeriGuard (AGSS) had a gross margin of 13.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is AmeriGuard's operating margin?

AmeriGuard (AGSS) had an operating margin of -13.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is AmeriGuard's net profit margin?

AmeriGuard (AGSS) had a net profit margin of -2.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is AmeriGuard's operating cash flow?

AmeriGuard (AGSS) recorded an outflow of $235K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are AmeriGuard's total assets?

AmeriGuard (AGSS) had $8.2M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does AmeriGuard have outstanding?

AmeriGuard (AGSS) had 89M shares outstanding as of fiscal year 2025.

What is AmeriGuard's current ratio?

AmeriGuard (AGSS) had a current ratio of 0.34 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is AmeriGuard's return on assets (ROA)?

AmeriGuard (AGSS) had a return on assets of -5.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is AmeriGuard's P/E ratio?

AmeriGuard (AGSS) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $1.7M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is AmeriGuard's price-to-sales ratio?

AmeriGuard (AGSS) trades at 0.1x sales, its market capitalization divided by revenue of $23.5M revenue, FY2025. The market capitalization is $1.7M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does AmeriGuard's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, AmeriGuard (AGSS) held $729K in cash, cash equivalents and investments, and reported an operating cash outflow of $235K over that year. Dividing the one by the other, the reported balance equals about 37 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Why is AmeriGuard's debt-to-equity ratio negative or not reported?

AmeriGuard (AGSS) has negative shareholder equity of -$3.5M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is AmeriGuard's Altman Z-Score?

AmeriGuard (AGSS) has an Altman Z-Score of 0.31, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is AmeriGuard's Piotroski F-Score?

AmeriGuard (AGSS) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are AmeriGuard's earnings high quality?

AmeriGuard (AGSS) reported a net loss of $488K while operations used $235K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.